Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Clinical trial NCT00435448 · TERMINATED

Trial details

NCT number: NCT00435448
Sponsor: Threshold Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Enlarged Prostate

Start date: 2005-06-01
Primary completion: 2006-12-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.